References
- Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149(4):778–789. doi:10.1002/ijc.33588
- Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. doi:10.3322/caac.21654
- Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, Büller HR. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol. 2000;18(17):3078–3083. doi:10.1200/JCO.2000.18.17.3078
- Potts JE, Iliescu CA, Lopez Mattei JC, et al. Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States. Eur Heart J. 2019;40(22):1790–1800. doi:10.1093/eurheartj/ehy769
- Nouhravesh N, Strange JE, Tønnesen J, et al. Prognosis of acute coronary syndrome stratified by cancer type and status – a nationwide cohort study. Am Heart J. 2022;43. doi:10.1016/j.ahj.2022.11.001
- Henriksen DP, Rasmussen L, Hansen MR, Hallas J, Pottegård A, Dalal K. Comparison of the five Danish regions regarding demographic characteristics, healthcare utilization, and medication use—a descriptive cross-sectional study. PLoS One. 2015;10(10):e0140197. doi:10.1371/journal.pone.0140197
- Sundhedsstyrelsen. Diagnostisk pakkeforløb; 2022. Available from: https://www.sst.dk/-/media/Udgivelser/2022/Pakkeforloeb/Diagnostisk-Pakkeforloeb.ashx. Accessed October 2, 2022.
- Sundhedsdatastyrelsen. Monitorering af kraeft aarsopgoerelse. Available from: https://sundhedsdatastyrelsen.dk/-/media/sds/filer/find-tal-og-analyser/sygdomme-og-behandlinger/kraeft/kraeft_monitorering/monitorering_kraeft_aarsopgoerelse_2021.pdf. Accessed October 2, 2022.
- Bleicher RJ, Ruth K, Sigurdson ER, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2(3):330–339. doi:10.1001/jamaoncol.2015.4508
- Kaltenmeier C, Shen C, Medich DS, et al. Time to surgery and colon cancer survival in the United States. Ann Surg. 2021;274(6):1025–1031. doi:10.1097/SLA.0000000000003745
- Fligor SC, Tsikis ST, Wang S, et al. Time to surgery in thoracic cancers and prioritization during COVID-19: a systematic review. J Thorac Dis. 2020;12(11):11. doi:10.21037/jtd-20-2400
- An D, Choi J, Lee J, et al. Time to surgery and survival in breast cancer. BMC Surg. 2022;22(1):388. doi:10.1186/s12893-022-01835-1
- Helqvist L, Erichsen R, Gammelager H, Johansen MB, Sørensen HT. Quality of ICD-10 colorectal cancer diagnosis codes in the Danish National Registry of Patients. Eur J Cancer Care. 2012;21(6):722–727. doi:10.1111/j.1365-2354.2012.01350.x
- Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi:10.2147/CLEP.S91125
- Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sørensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11(1):83. doi:10.1186/1471-2288-11-83
- Vesteghem C, Brøndum RF, Falkmer UG, Pottegård A, Poulsen LØ, Bøgsted M. High validity of the Danish National Patient Registry for systemic anticancer treatment registration from 2009 to 2019. Clin Epidemiol. 2021;13:1085–1094. doi:10.2147/CLEP.S332776
- Kearon C, Ageno W, Cannegieter SC, et al. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH. J Thromb Haemost. 2016;14(7):1480–1483. doi:10.1111/jth.13336
- Opfølgning efter tyktarmskræft. Kræftens Bekæmpelse. Available from: https://www.cancer.dk/tyktarmskraeft-coloncancer/kontrol-tyktarmskraeft/. Accessed July 14, 2022.
- Opfølgning efter endetarmskræft. Kræftens Bekæmpelse. Available from: https://www.cancer.dk/endetarmskraeft-rektumcancer/kontrol-endetarmskraeft/. Accessed July 14, 2022.
- Sundhedsstyrelsen. Pakkeforløb for lungekræft 2018; 2022. Available from: https://www.sst.dk/-/media/Udgivelser/2018/Lungekraeft/Pakkeforl%C3%B8b-for-lungekr%C3%A6ft-2018.ashx?sc_lang=da&hash=0312B32A6CB7E1473CA0DE4D38877BA5. Accessed July 14, 2022.
- Opfølgningsforløb efter brystkræft. Kræftens Bekæmpelse. Available from: https://www.cancer.dk/brystkraeft-mammacancer/kontrol-brystkraeft/. Accessed July 14, 2022.
- Danish Breast Cancer Cooperative Group. DBCG aarsrapport 2021. Available from: https://www.sundhed.dk/content/cms/79/4679_dbcgaarsrapport2021offentliggjort30062022.pdf. Accessed October 2, 2022.
- Asselain B, Barlow W, Bartlett J, et al. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol. 2018;19(1):27–39. doi:10.1016/S1470-2045(17)30777-5